Increased Antitrust Scrutiny and Enforcement in Tech: the Risks and Opportunities are Not Just for Big Tech Firms
Webinar | 04.15.20, 7:00 AM EDT - 8:00 AM EDT
On Wednesday, April 15, Crowell & Moring and Global Competition Review will host a webinar exploring how the recent increased antitrust scrutiny and enforcement related to large technology platforms will present risks and opportunities beyond big tech firms and impact companies across all industries. The discussion will also address how the COVID-19 pandemic is affecting these investigations worldwide. The webinar will be moderated by Crowell & Moring’s Andy Gavil.
The Panelists include:
- Alexis J. Gilman, Partner, Crowell & Moring
- Thomas De Meese, Partner, Crowell & Moring
- Jeane A. Thomas, Partner, Crowell & Moring
The webinar will cover, among other issues:
- Recent developments and increased scrutiny in the United States, European Union and elsewhere
- Enforcement actions involving innovation, non-price competition and nascent competitors that may have implications for tech enforcement
- Potential theories of harm, including:
-Consummated acquisitions
-Prospective acquisitions
-Conduct issues
-Non-traditional antitrust issues
The panel will commence at 11:00 AM EDT. Please register for the webinar by clicking the link here.
For more information on this topic, please be sure to read “Antitrust in the Digital Age,” the cover story of Crowell & Moring’s 2020 Regulatory Forecast.
For more information, please visit these areas: Brussels Practice, Antitrust and Competition — Brussels Practice, Technology — Brussels Practice, Antitrust and Competition
Participants
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26


